4-Aminopyridine
This graph shows the total number of publications written about "4-Aminopyridine" by people in the URMC Research Network by year, and whether "4-Aminopyridine" was a major or minor topic of these publication.
Below are the most recent publications written about "4-Aminopyridine" by people in Profiles.
-
Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR. A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol. 2010 Oct; 68(4):494-502.
-
Goodman AD, Hyland M. Dalfampridine in multiple sclerosis. Drugs Today (Barc). 2010 Sep; 46(9):635-9.
-
Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009 Feb 28; 373(9665):732-8.
-
Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 2008 Oct 7; 71(15):1134-41.
-
Goodman AD, Cohen JA, Cross A, Vollmer T, Rizzo M, Cohen R, Marinucci L, Blight AR. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Mult Scler. 2007 Apr; 13(3):357-68.
-
Kang N, Xu J, Xu Q, Nedergaard M, Kang J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J Neurophysiol. 2005 Dec; 94(6):4121-30.
-
Xu J, Kang N, Jiang L, Nedergaard M, Kang J. Activity-dependent long-term potentiation of intrinsic excitability in hippocampal CA1 pyramidal neurons. J Neurosci. 2005 Feb 16; 25(7):1750-60.
-
Noble M. The possible role of myelin destruction as a precipitating event in Alzheimer's disease. Neurobiol Aging. 2004 Jan; 25(1):25-31.
-
Rasband MN, Trimmer JS, Schwarz TL, Levinson SR, Ellisman MH, Schachner M, Shrager P. Potassium channel distribution, clustering, and function in remyelinating rat axons. J Neurosci. 1998 Jan 1; 18(1):36-47.
-
Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 1997 Apr; 48(4):817-21.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
